Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
106: Founder finance fails and how to fix them | James Segal of fin-house
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Diurnal Group Plc
Life Sciences
Alkindi®: On route to Europe
By
Dr Martin Hall
19 Dec 2017
Collagen Solutions Plc
Life Sciences
Targeting long-term sustainable growth
By
Dr Martin Hall
19 Dec 2017
Stay up-to-date with the latest research
Sign up to our newsletter
genedrive Plc
Life Sciences
Remodelled for growth
By
Dr Martin Hall
13 Dec 2017
ValiRx
Life Sciences
Clinical efficacy of VAL401
13 Dec 2017
Evgen Pharma
Life Sciences
Funded to the end of Phase II trials
By
Dr Martin Hall
11 Dec 2017
Advanced Oncotherapy
Life Sciences
Distribution agreement and capital increase
By
Dr Martin Hall
11 Dec 2017
Life Sciences
UK residential REITs: the start of a journey
By
Mike Foster
30 Nov 2017
Redx Pharma
Life Sciences
Streamlined and clean
By
Dr Martin Hall
13 Nov 2017
Alliance Pharma Plc
Life Sciences
Kelo-cote building international sales
By
Dr Martin Hall
17 Oct 2017
Avacta Group plc
Life Sciences
R&D accelerated to advance assets
By
Dr Martin Hall
16 Oct 2017
Tissue Regenix
Life Sciences
Dual revenue stream growth
11 Oct 2017
Prev
1
...
16
17
18
19
20
...
22
Next
